Structural basis of GD2 ganglioside and mimetic peptide recognition by 14G2a antibody

Molecular and Cellular Proteomics

Volumn 14, Issue 10, 2015, Pages 2577-2590

  Horwacik, Irena ^a   Golik, Przemyslaw ^a   Grudnik, Przemyslaw ^a   Kolinski, Michal ^b   Zdzalik, Michal ^a   Rokita, Hanna ^a   Dubin, Grzegorz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GANGLIOSIDE GD2; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14G2A; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; GANGLIOSIDE; GANGLIOSIDE, GD2;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; COMPLEMENTARITY DETERMINING REGION; COMPUTER MODEL; CONTROLLED STUDY; CRYSTAL STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; LIGAND BINDING; MOLECULAR DYNAMICS; MOUSE; MUTAGENESIS; NEUROBLASTOMA; NEUROBLASTOMA CELL LINE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; ANIMAL; BINDING SITE; CHEMISTRY; IMMUNOLOGY; METABOLISM; MOLECULAR MIMICRY; PROTEIN CONFORMATION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; CELL LINE, TUMOR; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MICE; MOLECULAR MIMICRY; PROTEIN CONFORMATION;

EID: 84942870291     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M115.052720     Document Type: Article

References (47)

1. Cheever, M. A., Allison, J. P., Ferris, A. S., Finn, O. J., Hastings, B. M., Hecht, T. T., Mellman, I., Prindiville, S. A., Viner, J. L., Weiner, L. M., and Matrisian, L. M. (2009) The prioritization of cancer antigens: A national cancer institute pilot project for the acceleration of translational research. Clin. Cancer Res. 15, 5323-5337
2. Roth, M., Linkowski, M., Tarim, J., Piperdi, S., Sowers, R., Geller, D., Gill, J., and Gorlick, R. (2014) Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer 120, 548-554
3. Yoshida, S., Fukumoto, S., Kawaguchi, H., Sato, S., Ueda, R., and Furukawa, K. (2001) Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res. 61, 4244-4252
4. Wu, Z. L., Schwartz, E., Seeger, R., and Ladisch, S. (1986) Expression of GD2 ganglioside by untreated primary human neuroblastomas. Cancer Res. 46, 440-443
5. Cheung, N. K., and Dyer, M. A. (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat. Rev. Cancer 13, 397-411
6. Horwacik, I., Durbas, M., Boratyn, E., Wegrzyn, P., and Rokita, H. (2013) Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells. Cancer Lett. 341, 248-264
7. Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., Shimada, H., Grupp, S. A., Seeger, R., Reynolds, C. P., Buxton, A., Reisfeld, R. A., Gillies, S. D., Cohn, S. L., Maris, J. M., and Sondel, P. M. (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N. Engl. J. Med. 363, 1324-1334
8. Dhillon, S. (2015) Dinutuximab: First global approval. Drugs 75, 923-927
9. Willison, H. J., and Yuki, N. (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125, 2591-2625
10. Pichla, S. L., Murali, R., and Burnett, R. M. (1997) The crystal structure of a Fab fragment to the melanoma-associated GD2 ganglioside. J. Struct. Biol. 119, 6-16
11. Ahmed, M., Goldgur, Y., Hu, J., Guo, H. F., and Cheung, N. K. (2013) In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors. PLoS One 8, e63359
12. Pincus, S. H., Smith, M. J., Jennings, H. J., Burritt, J. B., and Glee, P. M. (1998) Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen. J. Immunol. 160, 293-298
13. Horwacik, I., and Rokita, H. (2012) Application of molecular mimicry to target GD2 ganglioside, in Neuroblastoma-Present and Future, Hiroyuki, S., Editor. InTech. 251-270
14. Johnson, M. A., and Pinto, B. M. (2008) Structural and functional studies of peptide-carbohydrate mimicry. Top. Curr. Chem. 273, 55-116
15. Horwacik, I., Kurcinski, M., Bzowska, M., Kowalczyk, A. K., Czaplicki, D., Kolinski, A., and Rokita, H. (2011) Analysis and optimization of interactions between peptides mimicking the GD2 ganglioside and the monoclonal antibody 14G2a. Int. J. Mol. Med. 28, 47-57
16. Mujoo, K., Kipps, T. J., Yang, H. M., Cheresh, D. A., Wargalla, U., Sander, D. J., and Reisfeld, R. A. (1989) Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18. Cancer Res. 49, 2857-2861
17. Fields, C., O'Connell, D., Xiao, S., Lee, G. U., Billiald, P., and Muzard, J. (2013) Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies. Nat. Protoc. 8, 1125-1148
18. Fest, S., Huebener, N., Weixler, S., Bleeke, M., Zeng, Y., Strandsby, A., Volkmer-Engert, R., Landgraf, C., Gaedicke, G., Riemer, A. B., Michalsky, E., Jaeger, I. S., Preissner, R., Forster-Wald, E., Jensen-Jarolim, E., and Lode, H. N. (2006) Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases. Cancer Res. 66, 10567-10575
19. Jancarik, J., and Kim, S. H. (1991) Sparse matrix sampling: a screening metod for crystallization of proteins. J. Appl. Cryst. 24, 409-411
20. Kabsch, W. (2010) Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132
21. Battye, T.G., Kontogiannis, L., Johnson, O., Powell, H. R., and Leslie, A. G. (2011) iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 67, 271-281
22. Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M. Krissinel, E. B. Leslie, A. G. McCoy, A. McNicholas, S. J. Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A., and Wilson, K. S. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235-242
23. Evans, P. (2006) Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62, 72-82
24. McCoy, A. J. (2007) Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr. D Biol. Crystallogr. 63, 32-41
25. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501.
26. Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., and Vagin, A. A. (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355-367
27. Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221
28. Brünger, A. T. (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475
29. Aqvist, J., Medina, C., and Samuelsson, J. E. (1994) A new method for predicting binding affinity in computer-aided drug design. Protein Eng. 7, 385-391
30. Eswar, N., Webb, B., Marti-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M. Y., Pieper, U., and Sali, A. (2006) Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinformatics Chapter 5: Unit 5.6
31. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graph. 14, 33-38, 27-28
32. Koziara, K.B., Stroet, M. Malde, A.K., and Mark, A.E. (2014) Testing and validation of the Automated Topology Builder (ATB) version 2.0: Prediction of hydration free enthalpies. J. Comput. Aided Mol. Des. 28, 221-233
33. Lin, Z., and van Gunsteren, W. F. (2013) Refinement of the application of the GROMOS 54A7 force field to beta-peptides. J. Comput. Chem. 34, 2796-2805
34. Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B., and Lindahl, E. (2013) GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845-854
35. Talavera, A., Eriksson, A., Okvist, M., López-Requena, A., Fernández-Marrero, Y., Pérez, R., Moreno, E., and Krengel, U. (2009) Crystal structure of an anti-ganglioside antibody, and modelling of the functional mimicry of its NeuGc-GM3 antigen by an anti-idiotypic antibody. Mol. Immunol. 46, 3466-3475
36. Cygler, M., Rose, D. R., and Bundle, D. R. (1991) Recognition of a cellsurface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253, 442-445
37. Villeneuve, S., Souchon, H., Riottot, M. M., Mazie, J. C., Lei, P., Glaudemans, C. P., Kovac, P., Fournier, J. M., and Alzari, P. M. (2000) Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc. Natl. Acad. Sci. U. S. A. 97, 8433-8438
38. Asensio, J. L., Arda, A., Canada, F. J., and Jimenez-Barbero, J. (2013) Carbohydrate-aromatic interactions. Acc. Chem. Res. 46, 946-954
39. Benson, M. A., Fu, Z., Kim, J. J., and Baldwin, M. R. Unique ganglioside recognition strategies for clostridial neurotoxins. J. Biol. Chem. 286, 34015-34022
40. Attrill, H., Imamura, A., Sharma, R. S., Kiso, M., Crocker, P. R., and van Aalten, D. M. (2006) Siglec-7 undergoes a major conformational change when complexed with the alpha(2, 8)-disialylganglioside GT1b. J. Biol. Chem. 281, 32774-32783
41. Nagae, M., Ikeda, A., Hane, M., Hanashima, S., Kitajima, K., Sato, C., and Yamaguchi, Y. (2013) Crystal structure of anti-polysialic acid antibody single chain Fv fragment complexed with octasialic acid: insight into the binding preference for polysialic acid. J. Biol. Chem. 288, 33784-33796
42. Adams, G. P., Schier, R., Marshall, K., Wolf, E. J., McCall, A. M., Marks, J. D., and Weiner, L. M. (1998) Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies. Cancer Res. 58, 485-490
43. Oldenburg, K. R., Loganathan, D., Goldstein, I. J., Schultz, P. G., and Gallop, M. A. (1992) Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. U. S. A. 89, 5393-5397
44. Vyas, N. K., Vyas, M. N., Chervenak, M. C., Bundle, D. R., Pinto, B. M., and Quiocho, F. A. (2003) Structural basis of peptide-carbohydrate mimicry in an antibody-combining site. Proc. Natl. Acad. Sci. U. S. A. 100, 15023-15028
45. Tapryal, S., Gaur, V., Kaur, K. J., and Salunke, D. M. (2013) Structural evaluation of a mimicry-recognizing paratope: plasticity in antigen-antibody interactions manifests in molecular mimicry. J. Immunol. 191, 456-463
46. Cheung, N. K., Guo, H. F., Cheung, I. Y. (2000) Correlation of anti-idiotype network with survival following anti-G(D2) monoclonal antibody 3F8 therapy of stage 4 neuroblastoma. Med. Pediatr. Oncol. 35, 635-637
47. Wierzbicki, A., Gil, M., Ciesielski, M., Fenstermaker, R. A., Kaneko, Y., Rokita, H., Lau, J. T., and Kozbor, D. (2008) Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells. J. Immunol. 181, 6644-6653